|
Market Closed -
NYSE
04:00:03 09/09/2026 HKT
|
5-day change | 1st Jan Change | ||
| 324.69 USD | -1.89% |
|
-1.90% | -3.87% |
| 09-09 | Cencora's MWI Animal Health Merger With Covetrus Sees 'Intensified' FTC Scrutiny, RBC Says | MT |
| 09-08 | Cencora, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-08-2026 09:30 AM |
| Market Cap | 61.96B 53.27B 50.12B 45.74B 85.35B 5,874B 85.8B 594B 230B 3,002B 233B 228B 9,554B | P/E 2026 * |
17.8x | P/E 2027 * | 19.4x |
|---|---|---|---|---|---|
| Enterprise Value | 69.64B 59.88B 56.33B 51.41B 95.94B 6,602B 96.44B 667B 258B 3,375B 262B 256B 10,739B | EV / Sales 2026 * |
0.21x | EV / Sales 2027 * | 0.2x |
| Free-Float |
61.21% | Yield 2026 * |
0.74% | Yield 2027 * | 0.76% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| COR | Delayed | |
CBOE
| COR | Real-time | |
|
Mexican S.E.
| COR * | End-of-day quote | |
|
Boerse Muenchen
| ABG | Real-time | |
|
London S.E.
| 0HF3 | Delayed | |
|
Borsa Italiana
| 1COR | End-of-day quote | |
|
Tradegate
| ABG | Real-time | |
|
Berne S.E.
| ABG | End-of-day quote | |
|
Deutsche Boerse AG
| ABG | Delayed | |
|
Börse Stuttgart
| ABG | Delayed | |
|
Wiener Boerse
| ABC | End-of-day quote |
Last Transcript : Cencora, Inc.
| 1 day | -1.89% | ||
| 1 week | -1.90% | ||
| Current month | +0.34% | ||
| 1 month | +1.32% | ||
| 3 months | +18.47% | ||
| 6 months | -9.42% | ||
| Current year | -3.87% |
| 1 week | 323.05 |  | 338.71 |
| 1 month | 302.01 | | 338.71 |
| Current year | 244.82 | | 376.92 |
| 1 year | 244.82 | | 377.54 |
| 3 years | 172.41 | | 377.54 |
| 5 years | 113.68 | | 377.54 |
| 10 years | 68.38 | | 377.54 |
| Manager | Title | Age | Since |
|---|---|---|---|
Robert Mauch
CEO | Chief Executive Officer | 59 | 01/10/2024 |
Eva Boratto
DFI | Director of Finance/CFO | 59 | 29/06/2026 |
Pawan Verma
CTO | Chief Tech/Sci/R&D Officer | 50 | 04/11/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Lon Greenberg
BRD | Director/Board Member | 75 | 16/05/2013 |
Robert Mauch
BRD | Director/Board Member | 59 | 01/10/2024 |
D. Mark Durcan
CHM | Chairman | 64 | 01/10/2025 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/9/26 | Sell | Controller/Auditor | -985 | 0.0005% | ||
| 24/8/26 | Sell | General Counsel | -11,300 | 0.0058% | ||
| 31/7/26 | Free | Director | 97 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.89% | -1.90% | +9.01% | +82.72% | 61.96B | |
| -2.59% | -3.13% | -20.18% | +4.76% | 183B | |
| -1.89% | +0.38% | -0.65% | +15.55% | 118B | |
| -0.49% | -4.95% | +12.81% | +44.34% | 50.6B | |
| -3.05% | -4.29% | -6.51% | -32.86% | 48.78B | |
| -3.83% | -6.22% | +8.37% | -18.99% | 31.9B | |
| -5.19% | -1.20% | - | - | 30.44B | |
| -0.65% | -0.27% | +33.42% | -14.09% | 23.77B | |
| -2.51% | -8.14% | -13.24% | +5.88% | 22.26B | |
| -2.74% | -4.88% | -12.03% | -1.93% | 21.3B | |
| Average | -1.95% | -2.94% | +1.22% | +9.48% | 59.18B | |
| Weighted average by Cap. | -0.95% | -2.00% | -4.21% | +13.57% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 337B 290B 273B 249B 464B 31,965B 467B 3,231B 1,250B 16,338B 1,266B 1,238B 51,992B | 353B 303B 285B 261B 486B 33,458B 489B 3,382B 1,309B 17,101B 1,325B 1,296B 54,420B |
| Net income | 3.58B 3.08B 2.9B 2.64B 4.93B 339B 4.96B 34.31B 13.28B 173B 13.44B 13.15B 552B | 2.84B 2.45B 2.3B 2.1B 3.92B 270B 3.94B 27.27B 10.55B 138B 10.68B 10.45B 439B |
| Net Debt | 7.68B 6.61B 6.22B 5.67B 10.59B 728B 10.64B 73.65B 28.49B 372B 28.85B 28.22B 1,185B | 9.44B 8.11B 7.63B 6.97B 13B 895B 13.07B 90.44B 34.99B 457B 35.44B 34.66B 1,455B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | US$324.69 | -1.89% | 2,200,493 |
| 04/09/26 | US$330.95 | -1.86% | 1,027,638 |
| 03/09/26 | US$337.22 | +0.26% | 1,085,311 |
| 02/09/26 | US$336.36 | +1.63% | 1,398,344 |
| 01/09/26 | US$330.97 | +2.28% | 1,518,597 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- COR Stock
Select your edition
All financial news and data tailored to specific country editions
